Scinai Immunotherapeutics CEO Issues Letter to Shareholders ...Middle East

JERUSALEM , Jan. 4, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biological products, today published a letter from its CEO, Amir Reichman, addressing the Company's 2023...

Hence then, the article about scinai immunotherapeutics ceo issues letter to shareholders was published today ( Thursday 04/01/2024 - 02:21 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Scinai Immunotherapeutics CEO Issues Letter to Shareholders )

Also on site :

• Russian hockey legend Ovechkin refuses to wear LGBT tape
• After the Fire, Hope Valley Faces Its First Reckoning in 'When Calls the Heart' Season 13 Episode 3
• Simone Biles Stuns in Jonathan Owens-Inspired Outfit for NFL Playoff Game